163 related articles for article (PubMed ID: 37160530)
1. Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease.
Shamsher E; Khan RS; Davis BM; Dine K; Luong V; Somavarapu S; Cordeiro MF; Shindler KS
Neurotherapeutics; 2023 Jul; 20(4):1138-1153. PubMed ID: 37160530
[TBL] [Abstract][Full Text] [Related]
2. HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.
Khan RS; Dine K; Luna E; Ahlem C; Shindler KS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5744-51. PubMed ID: 25139738
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis.
McDougald DS; Dine KE; Zezulin AU; Bennett J; Shindler KS
Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1212-1220. PubMed ID: 29494741
[TBL] [Abstract][Full Text] [Related]
4. Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis.
Ross AG; Chaqour B; McDougald DS; Dine KE; Duong TT; Shindler RE; Yue J; Liu T; Shindler KS
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740955
[TBL] [Abstract][Full Text] [Related]
5. Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection.
Khan RS; Dine K; Wessel H; Brown L; Shindler KS
J Neuroophthalmol; 2019 Jun; 39(2):191-199. PubMed ID: 30829880
[TBL] [Abstract][Full Text] [Related]
6. Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis.
Smith AW; Rohrer B; Wheless L; Samantaray S; Ray SK; Inoue J; Azuma M; Banik NL
J Neurochem; 2016 Oct; 139(2):270-284. PubMed ID: 27513991
[TBL] [Abstract][Full Text] [Related]
7. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
Fonseca-Kelly Z; Nassrallah M; Uribe J; Khan RS; Dine K; Dutt M; Shindler KS
Front Neurol; 2012; 3():84. PubMed ID: 22654783
[TBL] [Abstract][Full Text] [Related]
9. Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis.
Khan RS; Ross AG; Willett K; Dine K; Banas R; Brown LR; Shindler KS
Neurotherapeutics; 2021 Jan; 18(1):448-459. PubMed ID: 33067748
[TBL] [Abstract][Full Text] [Related]
10. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.
Shindler KS; Ventura E; Dutt M; Elliott P; Fitzgerald DC; Rostami A
J Neuroophthalmol; 2010 Dec; 30(4):328-39. PubMed ID: 21107122
[TBL] [Abstract][Full Text] [Related]
11. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis.
Guo X; Harada C; Namekata K; Kimura A; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2696-703. PubMed ID: 21228387
[TBL] [Abstract][Full Text] [Related]
12. Targeted Krüppel-Like Factor 4 Gene Knock-Out in Retinal Ganglion Cells Improves Visual Function in Multiple Sclerosis Mouse Model.
Talla V; Koilkonda R
eNeuro; 2020; 7(2):. PubMed ID: 32165410
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 activation confers neuroprotection in experimental optic neuritis.
Shindler KS; Ventura E; Rex TS; Elliott P; Rostami A
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3602-9. PubMed ID: 17652729
[TBL] [Abstract][Full Text] [Related]
14. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
Larabee CM; Hu Y; Desai S; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():332-41. PubMed ID: 27122964
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.
Shindler KS; Ventura E; Dutt M; Rostami A
Exp Eye Res; 2008 Sep; 87(3):208-13. PubMed ID: 18653182
[TBL] [Abstract][Full Text] [Related]
16. Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis.
Dal Monte M; Cammalleri M; Locri F; Amato R; Marsili S; Rusciano D; Bagnoli P
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29517994
[TBL] [Abstract][Full Text] [Related]
17. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
Zeinali H; Baluchnejadmojarad T; Roghani M
Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463
[TBL] [Abstract][Full Text] [Related]
18. Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis.
Guo X; Harada C; Namekata K; Kikushima K; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
Neurosci Lett; 2009 Oct; 462(3):281-5. PubMed ID: 19616065
[TBL] [Abstract][Full Text] [Related]
19. Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.
Dietrich M; Helling N; Hilla A; Heskamp A; Issberner A; Hildebrandt T; Kohne Z; Küry P; Berndt C; Aktas O; Fischer D; Hartung HP; Albrecht P
J Neuroinflammation; 2018 Mar; 15(1):71. PubMed ID: 29514678
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model.
Horstmann L; Schmid H; Heinen AP; Kurschus FC; Dick HB; Joachim SC
J Neuroinflammation; 2013 Oct; 10():120. PubMed ID: 24090415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
